This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEE5D08R_M.jpg
Roku (NASDAQ:ROKU) 26% LOWER; reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4 million versus the consensus estimate of $804.13 million. Roku sees Q3 2022 revenue of $700 million, versus the consensus of $901.7 million.
DexCom (NASDAQ:DXCM) 8% LOWER; reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million. DexCom sees Q3 2022 revenue of $2.86 billion-2.91 billion, versus the consensus of $2.92 billion.
Amazon (NASDAQ:AMZN) 9% HIGHER; reported Q2 EPS of ($0.20), $0.33 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $121.2 billion versus the consensus estimate of $119.18 billion. Amazon sees Q3 2022 revenue of $125 billion-130 billion, versus the consensus of $126.4 billion.
Sarepta Therapeutics (NASDAQ:SRPT) 9% HIGHER; announced its intent to submit a Biologics License Application (BLA) seeking accelerated approval for SRP-9001 (delandistrogene moxeparvovec) to treat ambulant individuals with Duchenne muscular dystrophy. SRP-9001 is an investigational gene therapy for Duchenne being developed in partnership with Roche.
Intel (NASDAQ:INTC) 10% LOWER; reported Q2 EPS of $0.29, $0.41 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $15.3 billion versus the consensus estimate of $17.96 billion. Intel sees FY2022 EPS of $2.30, versus the consensus of $3.42. Intel sees FY2022 revenue of $65 billion-68 billion, versus the consensus of $74.3 billion. Intel sees Q3 2022 EPS of $0.35, versus the consensus of $0.87. Intel sees Q3 2022 revenue of $15 billion-16 billion, versus the consensus of $18.62 billion.
Trade Desk (NASDAQ:TTD) 9% LOWER; TTD and Michelle Hulst, the Company’s Chief Data Officer, agreed that Ms. Hulst will step down from her current position effective as of July 29, 2022. Upon her departure from the Company, it is intended that Ms. Hulst receive the benefits provided for an employment termination without cause as set forth in her previously filed Employment Agreement dated January 11, 2021.
Five9 (NASDAQ:FIVN) 10% HIGHER; reported Q2 EPS of $0.34, $0.16 better than the analyst estimate of $0.18. Revenue for the quarter came in at $189.4 million versus the consensus estimate of $180.12 million. Five9 sees FY2022 EPS of $1.38-$1.40, versus the consensus of $1.22. Five9 sees FY2022 revenue of $780.5 million-782.5 million, versus the consensus of $772.1 million. Five9 sees Q3 2022 EPS of $0.31-$0.33, versus the consensus of $0.30. Five9 sees Q3 2022 revenue of $192.5 million-193.5 million, versus the consensus of $192.3 million.
Deckers Brands (NYSE:DECK) 8% HIGHER; reported Q1 EPS of $1.66, $0.41 better than the analyst estimate of $1.25. Revenue for the quarter came in at $614.5 million versus the consensus estimate of $567.34 million. The Board of Directors Approved Additional Share Repurchase Authorization of $1.2 billion. Deckers Brands sees FY2023 EPS of $17.50-$18.35, versus the consensus of $17.98. Deckers Brands sees FY2023 revenue of $3.45-3.5 million, versus the consensus of $3.49 million.
Edwards Lifesciences (NYSE:EW) 7% LOWER; reported Q2 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.4 billion. Edwards Lifesciences sees Q3 2022 EPS of $0.58-$0.66, versus the consensus of $0.65. Edwards Lifesciences sees Q3 2022 revenue of $1.3 billion-1.37 billion, versus the consensus of $1.44 billion.
U.S. Steel (NYSE:X) 2% HIGHER; reported Q2 EPS of $3.86, $0.36 better than the analyst estimate of $3.50. Revenue for the quarter came in at $6.29 billion versus the consensus estimate of $5.81 billion.
Chevron (NYSE:CVX) 4% HIGHER; reported Q2 EPS of $5.82, $0.73 better than the analyst estimate of $5.09. Revenue for the quarter came in at $68.76 billion versus the consensus estimate of $57.96 billion.
Apple (NASDAQ:AAPL) 3% HIGHER; reported Q3 EPS of $1.20, $0.04 better than the analyst estimate of $1.16. Revenue for the quarter came in at $83 billion versus the consensus estimate of $82.59 billion.
Procter & Gamble (NYSE:PG) 5% LOWER; reported Q4 EPS of $1.21, $0.02 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $19.5 billion versus the consensus estimate of $19.37 billion.
Exxon Mobil (NYSE:XOM) 2% HIGHER; reported Q2 EPS of $4.21, $0.37 better than the analyst estimate of $3.84. Revenue for the quarter came in at $115.68 billion versus the consensus estimate of $94.97 billion.
